Orphan designation: Elafibranor Treatment of primary sclerosing cholangitis, 18/07/2025 Positive
Orphan designation: Elafibranor Treatment of primary sclerosing cholangitis, 18/07/2025 Positive
Orphan designation: Elafibranor Treatment of primary sclerosing cholangitis, 18/07/2025 Positive
Orphan designation: nuvisertib Treatment of myelofibrosis, 18/07/2025 Positive
Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023
Veterinary medicines European public assessment report (EPAR): Clevor, ropinirole, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Chanhold, selamectin, Status: Authorised
PSUSA/00002153/202412
Veterinary medicines European public assessment report (EPAR): Baycox Iron, toltrazuril,iron (III) ion, Status: Authorised
Verification application form
Warning about sharp rise in illegal medicines sold in the EU
Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)